Article

7EYE increases commitment to NXT performance lenses

7EYE by Panoptx is replacing its polycarbonate lens line with NXT Performance Sunlenses from Intercast, a division of PPG Industries.

Jackson Hogen, vice president of marketing and research and development for 7EYE, said, "We are extending our NXT lens collection to include all of our marine polarized lenses, effective immediately, and will be stepping up to NXT in our Re-ACT (Amplified Color Technology) lenses."

Also, 7EYE's increased commitment to PPG's NXT lenses is being reciprocated with marketing support from PPG that has allowed 7EYE to increase its advertising campaign substantially among ECP trade publications.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
© 2025 MJH Life Sciences

All rights reserved.